» Articles » PMID: 16150724

Mutation of Key Residues of RPE65 Abolishes Its Enzymatic Role As Isomerohydrolase in the Visual Cycle

Overview
Specialty Science
Date 2005 Sep 10
PMID 16150724
Citations 238
Authors
Affiliations
Soon will be listed here.
Abstract

RPE65 is essential for isomerization of vitamin A to the visual chromophore. Mutations in RPE65 cause early-onset blindness, and Rpe65-deficient mice lack 11-cis-retinal but overaccumulate alltrans-retinyl esters in the retinal pigment epithelium (RPE). RPE65 is proposed to be a substrate chaperone but may have an enzymatic role because it is closely related to carotenoid oxygenases. We hypothesize that, by analogy with other carotenoid oxygenases, the predicted iron-coordinating residues of RPE65 are essential for retinoid isomerization. To clarify RPE65's role in isomerization, we reconstituted a robust minimal visual cycle in 293-F cells. Only cells transfected with RPE65 constructs produced 11-cis-retinoids, but coexpression with lecithin:retinol acyltransferase was needed for high-level production. Accumulation was significant, amounting to >2 nmol of 11-cis-retinol per culture. Transfection with constructs harboring mutations in residues of RPE65 homologous to those required for interlinked enzymatic activity and iron coordination in related enzymes abolish this isomerization. Iron chelation also abolished isomerization activity. Mutating cysteines implicated in palmitoylation of RPE65 had generally little effect on isomerization activity. Mutations associated with Leber congenital amaurosis/early-onset blindness cause partial to total loss of isomerization activity in direct relation to their clinical effects. These findings establish a catalytic role, in conjunction with lecithin:retinol acyltransferase, for RPE65 in synthesis of 11-cis-retinol, and its identity as the isomerohydrolase.

Citing Articles

Higher throughput assays for understanding the pathogenicity of variants of unknown significance (VUS) in the RPE65 gene.

Pormehr L, Manian K, Cho H, Comander J bioRxiv. 2025; .

PMID: 39975398 PMC: 11838478. DOI: 10.1101/2025.01.31.635952.


Gene therapy for genetic diseases: challenges and future directions.

Qie B, Tuo J, Chen F, Ding H, Lyu L MedComm (2020). 2025; 6(2):e70091.

PMID: 39949979 PMC: 11822459. DOI: 10.1002/mco2.70091.


The importance of genetic counselling and testing in inherited eye diseases: A population-based retrospective study.

Kaminer Abargel M, Macarov M, Hendler K, Yahalom C PLoS One. 2025; 20(2):e0318492.

PMID: 39946424 PMC: 11825002. DOI: 10.1371/journal.pone.0318492.


Long-term experience with gene augmentation therapy in patients with inherited retinal disease associated with biallelic mutations in .

Lorenz B Med Genet. 2025; 37(1):47-56.

PMID: 39943983 PMC: 11812477. DOI: 10.1515/medgen-2024-2067.


Dual CRALBP isoforms unveiled: iPSC-derived retinal modeling and AAV2/5-RLBP1 gene transfer raise considerations for effective therapy.

Damodar K, Dubois G, Guillou L, Mamaeva D, Pequignot M, Erkilic N Mol Ther. 2024; 32(12):4319-4336.

PMID: 39385467 PMC: 11638835. DOI: 10.1016/j.ymthe.2024.10.004.


References
1.
Hamel C, Tsilou E, Harris E, Pfeffer B, Hooks J, Detrick B . A developmentally regulated microsomal protein specific for the pigment epithelium of the vertebrate retina. J Neurosci Res. 1993; 34(4):414-25. DOI: 10.1002/jnr.490340406. View

2.
SAARI J, Bredberg D, Noy N . Control of substrate flow at a branch in the visual cycle. Biochemistry. 1994; 33(10):3106-12. DOI: 10.1021/bi00176a045. View

3.
Okajima T, Wiggert B, Chader G, Pepperberg D . Retinoid processing in retinal pigment epithelium of toad (Bufo marinus). J Biol Chem. 1994; 269(35):21983-9. View

4.
Humphrey W, Dalke A, Schulten K . VMD: visual molecular dynamics. J Mol Graph. 1996; 14(1):33-8, 27-8. DOI: 10.1016/0263-7855(96)00018-5. View

5.
Schwartz S, Tan B, Gage D, Zeevaart J, McCarty D . Specific oxidative cleavage of carotenoids by VP14 of maize. Science. 1997; 276(5320):1872-4. DOI: 10.1126/science.276.5320.1872. View